| NDC Code | 0003-0371-13 |
|---|
| Package Description | 1 VIAL, SINGLE-USE in 1 CARTON (0003-0371-13) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE |
|---|
| Product NDC | 0003-0371 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Nulojix |
|---|
| Non-Proprietary Name | Belatacept |
|---|
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
|---|
| Usage | INTRAVENOUS |
|---|
| Start Marketing Date | 20110615 |
|---|
| Marketing Category Name | BLA |
|---|
| Application Number | BLA125288 |
|---|
| Manufacturer | E.R. Squibb & Sons, L.L.C. |
|---|
| Substance Name | BELATACEPT |
|---|
| Strength | 250 |
|---|
| Strength Unit | mg/1 |
|---|
| Pharmacy Classes | CD80-directed Antibody Interactions [MoA], CD86-directed Antibody Interactions [MoA], Selective T Cell Costimulation Blocker [EPC], T Lymphocyte Costimulation Activity Blockade [PE] |
|---|